Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF PILL
Set alert
14.48 USD -0.73 -4.80%
At close · Nov 2
14.50 +0.02 +0.14%
After hours · Nov 2, 6:13 PM ET
14.37 Day range 15.20
7.75 52-week range 24.15
- YTD
- +17.72%
- 1 year
- +62.88%
- Open
- 14.79
- Prev close
- 15.21
- Mkt cap
- 31.53M
- Vol
- 76.83K
- Avg vol
- 52.14K
- EPS
- 0.35853
- P/E
- 40.39
- Div yield
- 0.00%
More statistics
- Low
- 14.37
- High
- 15.20
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.83
- 200-d avg
- 7.64
30m chart
Built from the cached five-day intraday bars.
Signals (19)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:25 PM | 3 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:25 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:25 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 4 days ago |
| RSI: Overbought | Oct 28, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:55 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:25 PM | 5 days ago |
| RSI: Overbought | Oct 28, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:25 PM | 5 days ago |
| SMA: Bullish | Oct 28, 10:25 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 5 days ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 13.48
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 8.83
- 200-day average
- 7.64
About Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
News
- Top Performing Leveraged/Inverse ETFs: 06/14/2026
- Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
- Top Performing Leveraged/Inverse ETFs: 12/14/2025
- Top Performing Leveraged/Inverse ETFs: 11/16/2025
- Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
- Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
- As M&A Deals Rise, Can Biotech Pharma Break Loose?
- Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
- Top Performing Leveraged/Inverse ETFs: 08/17/2025
- CURE: Make an Adventurous Bet on an Undervalued Sector
Your note
Sign in to keep a note on PILL — it syncs with the Stock Master app.